Skip to main content
. 2007 Jul 20;25(29-5):5290–5300. doi: 10.1016/j.vaccine.2007.05.010

Table 1.

Frequency of clinical symptoms

Clinical symptoms of CVL HASPB1 H1 HASPB1 + H1 Montanide MML MPL Control
Lymphadenopathy 37.5 25 50 50 43 50 62.5
Alopecia 37.5 50 62.5 25 71.4 100 87.5
Cutaneous lesions 37.5 25 37.5 25 28.5 75 62.5
Onychogryphosis 50 25 37.5 50 57 50 62.5
Keratoconjuctivitis 37.5 37.5 50 50 43 75 50
Weight loss 37.5 25 25 50 28.5 50 62.5

Values represent the percentage of animals in each group that showed the specific symptom of CVL at week 64.